Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED)

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Retained Earnings (Accumulated Deficit)
Common Stock
Additional Paid-In Capital
Balance, shares at Dec. 31, 2023     2,382,356  
Balance, amount at Dec. 31, 2023 $ (2,205,843) $ (123,581,714) $ 2,383 $ 121,373,488
Employee and director equity-based compensation 112,104 0 $ 0 112,104
Private sales of common stock - other, shares     350,633  
Private sales of common stock - other, amount 972,544 0 $ 351 972,193
Private sales of common stock - related party, shares     56,666  
Private sales of common stock - related party, amount 130,782 0 $ 57 130,725
Net loss for the three months ended March 31, 2024 (1,278,486) (1,278,486) $ 0 0
Balance, shares at Mar. 31, 2024     2,789,655  
Balance, amount at Mar. 31, 2024 (2,268,899) (124,860,200) $ 2,791 122,588,510
Balance, shares at Dec. 31, 2024     3,621,335  
Balance, amount at Dec. 31, 2024 (514,897) (136,966,550) $ 3,621 136,448,032
Net loss for the three months ended March 31, 2024 (4,211,188) (4,211,188)    
Employee and director equity-based compensation, shares     38,378  
Employee and director equity-based compensation, amount 600,545   $ 38 600,507
Exchange agreements - other, shares     84,060  
Exchange agreements - other, amount 1,645,788   $ 84 1,645,704
Exchange agreements - related party, shares     47,320  
Exchange agreements - related party, amount 862,473   $ 48 862,425
Balance, shares at Mar. 31, 2025     3,791,093  
Balance, amount at Mar. 31, 2025 $ (1,617,279) $ (141,177,738) $ 3,791 $ 139,556,668